KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fulgent Genetics (FLGT) Tax Provisions (2016 - 2025)

Fulgent Genetics' Tax Provisions history spans 10 years, with the latest figure at -$683000.0 for Q3 2025.

  • For Q3 2025, Tax Provisions rose 82.03% year-over-year to -$683000.0; the TTM value through Sep 2025 reached -$4.6 million, up 73.16%, while the annual FY2024 figure was -$8.1 million, 805.03% down from the prior year.
  • Tax Provisions for Q3 2025 was -$683000.0 at Fulgent Genetics, up from -$2.3 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $66.5 million in Q1 2021 and bottomed at -$10.9 million in Q4 2023.
  • The 5-year median for Tax Provisions is -$327000.0 (2024), against an average of $10.9 million.
  • The largest annual shift saw Tax Provisions soared 195526.47% in 2021 before it tumbled 217.23% in 2023.
  • A 5-year view of Tax Provisions shows it stood at $47.1 million in 2021, then plummeted by 119.91% to -$9.4 million in 2022, then dropped by 15.73% to -$10.9 million in 2023, then soared by 83.1% to -$1.8 million in 2024, then surged by 62.8% to -$683000.0 in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Tax Provisions are -$683000.0 (Q3 2025), -$2.3 million (Q2 2025), and $176000.0 (Q1 2025).